Quick Search:       Advanced Search
Chinese Version 
Online office
Journal Online
Download
Top
Links

扫描微信二维码,获取更多信息
Identifying the targets for treatment of liver fibrosis and hepatocellular carcinoma from both Western medicine and Chinese medicine
  
View Full Text  View/Add Comment  Download reader
KeyWord:liver fibrosis  hepatocellular carcinoma  bone morphogenetic protein  integrative medicine
Author NameAffiliationE-mail
Yuewen Gong Faculties of Pharmacy and Medicine, University of Manitoba, 750 McDermot Avenue Winnipeg, Manitoba, Canada, R3E 0T5 ygong@cc.umanitoba.ca 
Hits: 1370
Download times: 1099
Abstract:
      Liver fibrosis and hepatocellular carcinoma (HCC) are emerging health problems worldwide. Number of death due to HCC was steadily increased during the last decade. Although liver fibrosis and HCC have been investigated extensively, there are no successful and/or satisfactory therapies especially for patients with HCC. From our understanding of both Western medicine and Chinese medicine, it could identify the targets in liver fibrosis and HCC for intervention with Chinese medicine such as bone morphogenetic protein 4 (BMP-4). BMP-4 expression was significantly increased in both liver fibrosis and HCC and saponin class of certain Chinese herbs could regulate its expression. Therefore, BMP-4 could be one of the targets for treatment of liver fibrosis and HCC from integrative medicine.
Close